Bio-Rad Laboratories Class B
BIO.B
5 hedge funds and large institutions have $8.11M invested in Bio-Rad Laboratories Class B in 2017 Q2 according to their latest regulatory filings, with funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 0 closing their positions.
36% more capital invested
Capital invested by funds: $5.98M → $8.11M (+$2.13M)
0.12% more ownership
Funds ownership: 0.58% → 0.7% (+0.12%)
0% more funds holding
Funds holding: 5 → 5 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$1.32M |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$29.5K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CL
1
CSS LLC
Chicago,
Illinois
| $5.02M | – | – | – |
|
2
Dimensional Fund Advisors
Austin,
Texas
| $1.45M | – | – | – |
|
|
3
Bank of America
Charlotte,
North Carolina
| $1.35M | +$1.32M | +6,000 | +120,000% |
|
4
Renaissance Technologies
New York
| $248K | – | – | – |
|
|
5
UBS Group
Zurich,
Switzerland
| $45K | +$29.5K | +134 | +203% |
|
BIO.B Hedge Fund Activity: Q2 2017 in Review
5 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class B (BIO.B) for Q2 2017, worth a combined $8.11M — up 36% from $5.98M a quarter earlier.
Fund positioning in BIO.B was balanced in Q2 2017: 0 funds opened new positions, 0 closed out, 2 added to existing stakes and 0 trimmed.
The largest buyer was Bank of America, adding an estimated $1.32M.
- 5 institutional investors held Bio-Rad Laboratories Class B (BIO.B) as of Q2 2017, unchanged from Q1 2017.
- Funds reported $8.11M of Bio-Rad Laboratories Class B stock for Q2 2017, up 36% quarter-over-quarter.
- 0 funds opened new Bio-Rad Laboratories Class B positions in Q2 2017 and 0 closed out.
- The largest Bio-Rad Laboratories Class B buyer in Q2 2017 was Bank of America, an estimated $1.32M added.
Based on aggregated 13F filings for Q2 2017.